BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 31182617)

  • 1. Evaluation of the Protective Ability of the Treponema pallidum subsp.
    Haynes AM; Godornes C; Ke W; Giacani L
    Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31182617
    [No Abstract]   [Full Text] [Related]  

  • 2. Transcription of TP0126, Treponema pallidum putative OmpW homolog, is regulated by the length of a homopolymeric guanosine repeat.
    Giacani L; Brandt SL; Ke W; Reid TB; Molini BJ; Iverson-Cabral S; Ciccarese G; Drago F; Lukehart SA; Centurion-Lara A
    Infect Immun; 2015 Jun; 83(6):2275-89. PubMed ID: 25802057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional and immunological analysis of the putative outer membrane protein and vaccine candidate TprL of Treponema pallidum.
    Haynes AM; Fernandez M; Romeis E; Mitjà O; Konda KA; Vargas SK; Eguiluz M; Caceres CF; Klausner JD; Giacani L
    PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008812. PubMed ID: 33497377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-pathogenic Borrelia burgdorferi expressing Treponema pallidum TprK and Tp0435 antigens as a novel approach to evaluate syphilis vaccine candidates.
    Parveen N; Fernandez MC; Haynes AM; Zhang RL; Godornes BC; Centurion-Lara A; Giacani L
    Vaccine; 2019 Mar; 37(13):1807-1818. PubMed ID: 30797635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence Variation of Rare Outer Membrane Protein β-Barrel Domains in Clinical Strains Provides Insights into the Evolution of
    Kumar S; Caimano MJ; Anand A; Dey A; Hawley KL; LeDoyt ME; La Vake CJ; Cruz AR; Ramirez LG; Paštěková L; Bezsonova I; Šmajs D; Salazar JC; Radolf JD
    mBio; 2018 Jun; 9(3):. PubMed ID: 29895642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two Potential Syphilis Vaccine Candidates Inhibit Dissemination of
    Xu M; Xie Y; Zheng K; Luo H; Tan M; Zhao F; Zeng T; Wu Y
    Front Immunol; 2021; 12():759474. PubMed ID: 34899710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological evaluation and cellular location analysis of the TprI antigen of Treponema pallidum subsp. pallidum.
    Giacani L; Sambri V; Marangoni A; Cavrini F; Storni E; Donati M; Corona S; Lanzarini P; Cevenini R
    Infect Immun; 2005 Jun; 73(6):3817-22. PubMed ID: 15908421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Function and protective capacity of Treponema pallidum subsp. pallidum glycerophosphodiester phosphodiesterase.
    Cameron CE; Castro C; Lukehart SA; Van Voorhis WC
    Infect Immun; 1998 Dec; 66(12):5763-70. PubMed ID: 9826352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that immunization with TP0751, a bipartite Treponema pallidum lipoprotein with an intrinsically disordered region and lipocalin fold, fails to protect in the rabbit model of experimental syphilis.
    Luthra A; Montezuma-Rusca JM; La Vake CJ; LeDoyt M; Delgado KN; Davenport TC; Fiel-Gan M; Caimano MJ; Radolf JD; Hawley KL
    PLoS Pathog; 2020 Sep; 16(9):e1008871. PubMed ID: 32936831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subfamily I Treponema pallidum repeat protein family: sequence variation and immunity.
    Sun ES; Molini BJ; Barrett LK; Centurion-Lara A; Lukehart SA; Van Voorhis WC
    Microbes Infect; 2004 Jul; 6(8):725-37. PubMed ID: 15207819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of cell-surface exposure and vaccinogenic potentials of Treponema pallidum candidate outer membrane proteins.
    Tomson FL; Conley PG; Norgard MV; Hagman KE
    Microbes Infect; 2007 Sep; 9(11):1267-75. PubMed ID: 17890130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Modeling of the Treponema pallidum Outer Membrane Protein Repertoire: a Road Map for Deconvolution of Syphilis Pathogenesis and Development of a Syphilis Vaccine.
    Hawley KL; Montezuma-Rusca JM; Delgado KN; Singh N; Uversky VN; Caimano MJ; Radolf JD; Luthra A
    J Bacteriol; 2021 Jul; 203(15):e0008221. PubMed ID: 33972353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and protective efficacy against Treponema pallidum in New Zealand rabbits immunized with plasmid DNA encoding flagellin.
    Zheng K; Xu M; Xiao Y; Luo H; Xie Y; Yu J; Tan M; Li Y; Zhao F; Zeng T; Wu Y
    Emerg Microbes Infect; 2018 Nov; 7(1):177. PubMed ID: 30405111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A defined syphilis vaccine candidate inhibits dissemination of Treponema pallidum subspecies pallidum.
    Lithgow KV; Hof R; Wetherell C; Phillips D; Houston S; Cameron CE
    Nat Commun; 2017 Feb; 8():14273. PubMed ID: 28145405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TprK protein of Treponema pallidum is periplasmic and is not a target of opsonic antibody or protective immunity.
    Hazlett KR; Sellati TJ; Nguyen TT; Cox DL; Clawson ML; Caimano MJ; Radolf JD
    J Exp Med; 2001 May; 193(9):1015-26. PubMed ID: 11342586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with the N-terminal portion of Treponema pallidum repeat protein K attenuates syphilitic lesion development in the rabbit model.
    Morgan CA; Lukehart SA; Van Voorhis WC
    Infect Immun; 2002 Dec; 70(12):6811-6. PubMed ID: 12438357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of Full-Length TprK Diversity in Treponema pallidum subsp.
    Addetia A; Lin MJ; Phung Q; Xie H; Huang ML; Ciccarese G; Dal Conte I; Cusini M; Drago F; Giacani L; Greninger AL
    mBio; 2020 Oct; 11(5):. PubMed ID: 33109767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treponemicidal antibody measured by the "washed-killing" assay correlates with immunity in experimental rabbit syphilis.
    Lewinski MA; Miller JN; Champion CI; Walker EM; Borenstein LA; Gayek RJ; Lovett MA; Blanco DR
    Sex Transm Dis; 1995; 22(1):31-8. PubMed ID: 7709323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Homology Model Reveals Novel Structural Features and an Immunodominant Surface Loop/Opsonic Target in the Treponema pallidum BamA Ortholog TP_0326.
    Luthra A; Anand A; Hawley KL; LeDoyt M; La Vake CJ; Caimano MJ; Cruz AR; Salazar JC; Radolf JD
    J Bacteriol; 2015 Jun; 197(11):1906-20. PubMed ID: 25825429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced immune response and protective efficacy of a Treponema pallidum Tp92 DNA vaccine vectored by chitosan nanoparticles and adjuvanted with IL-2.
    Zhao F; Wu Y; Zhang X; Yu J; Gu W; Liu S; Zeng T; Zhang Y; Wang S
    Hum Vaccin; 2011 Oct; 7(10):1083-9. PubMed ID: 21941092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.